Virtonomy Revenue and Competitors

Munich, Germany

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Virtonomy's estimated annual revenue is currently $7.3M per year.(i)
  • Virtonomy's estimated revenue per employee is $251,000

Employee Data

  • Virtonomy has 29 Employees.(i)
  • Virtonomy grew their employee count by 7% last year.

Virtonomy's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$19.6M7811%N/AN/A
#2
$142.3M567-3%N/AN/A
#3
$8.5M340%N/AN/A
#4
$58.7M23438%N/AN/A
#5
$15.1M6011%N/AN/A
#6
$73.5M29328%N/AN/A
#7
$28.4M11314%N/AN/A
#8
$22.3M8935%N/AN/A
#9
$96.4M384N/AN/AN/A
#10
$24.1M964%N/AN/A
Add Company

What Is Virtonomy?

Virtonomy is shortening time-to-market of medical products by conducting data driven studies on virtual patients. Our solution is based on an ever-expanding database to reflect anatomical variability, demographic diversity and pathological conditions. We support medical device manufacturers in the various phases of the product life cycle, from concept phase, over pre-clinical evaluation to post-market surveillance: better understand the target anatomy, find the optimal fit of the device to treat the maximum number of patients, identify the right in-vivo model, and improve clinical trials by proper sub-population selection. Virtonomy is headquartered in Munich, Germany, and combines an interdisciplinary team of experts in medical engineering, image and data processing, visualization and clinical practice.

keywords:N/A

N/A

Total Funding

29

Number of Employees

$7.3M

Revenue (est)

7%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Virtonomy News

2022-04-06 - In Silico Clinical Trials Market Revenue to Cross USD 6830.99 ...

InSilico Trials Technologies; FEops; CADFEM Medical GmbH; Dassault Systemes SE; Virtonomy GmbH; Certara Inc.; Computational Life;...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.9M297%N/A
#2
N/A29142%N/A
#3
$6.7M294%N/A
#4
$2.9M297%N/A
#5
$2.9M290%N/A